Clinical criteria and diagnostic assessment of fibromyalgia: position statement of the Italian Society of Neurology-Neuropathic Pain Study Group.
Corneal confocal microscopy
Diagnostic criteria
Fibromyalgia
Heart rate variability
Laser-evoked potentials
Skin biopsy
Small-fiber neuropathy
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
02
03
2023
accepted:
25
04
2023
medline:
12
6
2023
pubmed:
24
5
2023
entrez:
24
5
2023
Statut:
ppublish
Résumé
The role of central and/or peripheral nervous system dysfunction is basically fundamental in fibromyalgia. The aim of this position statement on behalf of the Neuropathic Pain Study Group of the Italian Society of Neurology is to give practical guidelines for the clinical and instrumental assessment of fibromyalgia (FM) in the neurological clinical practice, taking into consideration recent studies. Criteria for study selection and consideration were original studies, case-controls design, use of standardized methodologies for clinical practice, and FM diagnosis with ACR criteria (2010, 2011, 2016). ACR criteria were revised. For diagnostic procedure of small-fiber pathology, 47 studies were totally considered. Recent diagnostic criteria should be applied (ACR, 2016). A rheumatologic visit seems mandatory. The involvement of small fibers should request at least 2 among HRV + SSR and/or laser-evoked responses and/or skin biopsy and/or corneal confocal microscopy, eventually followed by monitoring of metabolic and/or immunological/ and or/paraneoplastic basis, to be repeated at 1-year follow-up. The correct diagnostic approach to FM could promote the exclusion of the known causes of small-fiber impairment. The research toward common genetic factors would be useful to promote a more specific therapeutic approach.
Sections du résumé
BACKGROUND
BACKGROUND
The role of central and/or peripheral nervous system dysfunction is basically fundamental in fibromyalgia.
AIM
OBJECTIVE
The aim of this position statement on behalf of the Neuropathic Pain Study Group of the Italian Society of Neurology is to give practical guidelines for the clinical and instrumental assessment of fibromyalgia (FM) in the neurological clinical practice, taking into consideration recent studies.
METHODS
METHODS
Criteria for study selection and consideration were original studies, case-controls design, use of standardized methodologies for clinical practice, and FM diagnosis with ACR criteria (2010, 2011, 2016).
RESULTS
RESULTS
ACR criteria were revised. For diagnostic procedure of small-fiber pathology, 47 studies were totally considered. Recent diagnostic criteria should be applied (ACR, 2016). A rheumatologic visit seems mandatory. The involvement of small fibers should request at least 2 among HRV + SSR and/or laser-evoked responses and/or skin biopsy and/or corneal confocal microscopy, eventually followed by monitoring of metabolic and/or immunological/ and or/paraneoplastic basis, to be repeated at 1-year follow-up.
CONCLUSIONS
CONCLUSIONS
The correct diagnostic approach to FM could promote the exclusion of the known causes of small-fiber impairment. The research toward common genetic factors would be useful to promote a more specific therapeutic approach.
Identifiants
pubmed: 37222872
doi: 10.1007/s10072-023-06836-3
pii: 10.1007/s10072-023-06836-3
pmc: PMC10257633
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2561-2574Informations de copyright
© 2023. The Author(s).
Références
Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):74-80
pubmed: 28681708
J Neurol. 2014 Mar;261(3):461-72
pubmed: 24366650
J Exerc Rehabil. 2022 Apr 26;18(2):133-140
pubmed: 35582683
Arthritis Rheum. 1985 Feb;28(2):138-45
pubmed: 3871615
Health Qual Life Outcomes. 2007 Feb 12;5:9
pubmed: 17295915
J Basic Clin Physiol Pharmacol. 2021 Feb 09;32(6):1021-1029
pubmed: 33638318
Pain. 2017 Feb;158(2):261-272
pubmed: 27893485
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Pain. 2013 Nov;154(11):2310-2316
pubmed: 23748113
Semin Arthritis Rheum. 2015 Oct;45(2):214-9
pubmed: 26094164
Pediatr Rheumatol Online J. 2012 Jun 15;10(1):16
pubmed: 22704360
Brain. 2013 Jun;136(Pt 6):1857-67
pubmed: 23474848
Cornea. 2018 Feb;37(2):205-210
pubmed: 29135602
Pain. 2023 Apr 19;:
pubmed: 37079850
Pain Pract. 2020 Apr;20(4):348-356
pubmed: 31705738
Pain. 2020 Oct;161(10):2385-2393
pubmed: 32897040
Ann Neurol. 2019 Oct;86(4):504-516
pubmed: 31376174
Rheum Dis Clin North Am. 2021 Nov;47(4):725-736
pubmed: 34635301
Eur J Pain. 2019 Oct;23(9):1586-1595
pubmed: 31162787
J Peripher Nerv Syst. 2020 Mar;25(1):9-18
pubmed: 31846167
Front Neurosci. 2020 Aug 04;14:788
pubmed: 32848561
Neurosci Lett. 2010 Feb 19;470(3):158-61
pubmed: 19481585
Pain Med. 2022 Dec 1;23(12):1928-1938
pubmed: 35652761
Pain. 2016 Nov;157(11):2493-2503
pubmed: 27429177
Clin Exp Rheumatol. 2015 Jan-Feb;33(1 Suppl 88):S68-72
pubmed: 25786046
Eur J Pain. 2020 Sep;24(8):1537-1547
pubmed: 32478943
Arthritis Rheum. 1990 Feb;33(2):160-72
pubmed: 2306288
J Rheumatol. 2021 Apr;48(4):575-578
pubmed: 32801135
Pain. 2015 Nov;156(11):2319-2325
pubmed: 26164586
J Rheumatol. 2020 Jan;47(1):140-148
pubmed: 31203217
J Pediatr. 2010 May;156(5):838-40
pubmed: 20171654
J Rheumatol. 2011 Jun;38(6):1113-22
pubmed: 21285161
Pain Med. 2013 Jun;14(6):895-915
pubmed: 23691965
Ann Neurol. 2014 Feb;75(2):196-208
pubmed: 24243538
Clin Exp Rheumatol. 2022 Jul 27;:
pubmed: 35916296
Clin Exp Rheumatol. 2000 May-Jun;18(3):415-9
pubmed: 10895386
Front Physiol. 2018 Aug 17;9:1118
pubmed: 30174611
Eur J Pain. 2020 Feb;24(2):448-456
pubmed: 31670448
Pain Res Treat. 2017;2017:9747148
pubmed: 29093972
J Clin Rheumatol. 2013 Apr;19(3):111-4
pubmed: 23519175
Pain Rep. 2021 Mar 10;6(1):e901
pubmed: 33718743
Mitochondrion. 2015 Mar;21:69-75
pubmed: 25662535
Sci Rep. 2016 Mar 23;6:23573
pubmed: 27006259
Eur J Pain. 2023 Jan;27(1):163-173
pubmed: 36314856
Eur J Pain. 2021 Mar;25(3):714-724
pubmed: 33259659
J Pediatr. 2016 Feb;169:181-7.e1
pubmed: 26545727
J Pain. 2011 Jan;12(1):116-24
pubmed: 20685171
J Rheumatol. 2015 Dec;42(12):2427-33
pubmed: 26373565
Muscle Nerve. 2018 Nov;58(5):625-630
pubmed: 29572887
Muscle Nerve. 2022 Jan;65(1):10-28
pubmed: 34374103
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
J Clin Rheumatol. 2021 Sep 1;27(6S):S278-S283
pubmed: 32826659
J Clin Neurophysiol. 2017 Mar;34(2):139-143
pubmed: 27753734
Clin Neurophysiol. 2022 Mar;135:96-106
pubmed: 35074721
Eur J Rheumatol. 2018 Jul;5(2):104-110
pubmed: 30185358
Lancet. 2021 May 29;397(10289):2098-2110
pubmed: 34062144
J Clin Invest. 2021 Jul 1;131(13):
pubmed: 34196305
Semin Arthritis Rheum. 2016 Dec;46(3):319-329
pubmed: 27916278
Pediatrics. 1998 Mar;101(3 Pt 1):377-82
pubmed: 9481000
Pain Rep. 2017 Dec 16;3(1):e633
pubmed: 29430562
Int J Exerc Sci. 2017 Dec 01;10(8):1184-1195
pubmed: 29399247
Exp Neurol. 2010 May;223(1):245-50
pubmed: 19748505
PLoS One. 2020 Jan 13;15(1):e0227674
pubmed: 31929578
Pediatrics. 2000 Nov;106(5):E70
pubmed: 11061807
Pain. 1994 Aug;58(2):185-193
pubmed: 7816486
Br J Pain. 2018 Nov;12(4):250-256
pubmed: 30349699